BMJ  2003;327:E237-E238 (4 October), doi:10.1136/bmjusa.03070002 (published 30 July 2003)

BMJ USA: Editorial

More misleading science from the tobacco industry

Delaying clean air laws through disinformation

From BMJ USA 2003;July:352

The article by Enstrom and Kabat (p 369) is the latest in a long series of publications funded by the tobacco industry that report little or no relationship between environmental tobacco smoke (ETS) and disease.1 The current study has an aura of legitimacy because it is drawn from the American Cancer Society (ACS) Cancer Prevention Study I (CPS-I), a landmark prospective study of the hazards of active smoking,2 and because the analyses are based on nearly 40 years of data. Despite these apparent strengths, the study by Enstrom and Kabat is uninformative and its conclusions are exaggerated.

Indeed, the negative conclusions were entirely predictable from the outset because of the flawed way in which exposure to ETS was classified. CPS-I collected no information on ETS exposure other than the smoking status of the spouse. The study began in 1959, an era in which secondhand smoke was pervasive; virtually everyone was exposed at work, in social settings, or in other activities of daily living. Enstrom and Kabat therefore could not identify a comparison group of "unexposed" persons. Their analyses essentially compare nonsmokers married to a smoking spouse to nonsmokers with other sources of ETS exposure. This potential for misclassification was further exacerbated in the final 26 years of follow-up after 1972, when no updated information on the smoking status of the spouse was collected. Many of the spouses who reported smoking at the start of the study would have quit, died, or ended the marriage, yet the surviving partner was still classified as "exposed" in the analysis. Enstrom and Kabat could not distinguish persons with continuing exposure to ETS from those with past exposure, or persons with multiple sources of ETS exposure from those exposed only to spousal smoking.

This is not the first time that tobacco industry consultants have published misleading reports about ETS exposure based on flawed analyses of ACS cohort studies. In 1995, LeVois and Layard reported no association between ETS exposure and coronary heart disease (CHD) mortality either in CPS-I or in CPS-II, an even larger ACS cohort study begun in 1982.3 ACS repeatedly communicated to these researchers and to Enstrom that CPS-I was not informative for evaluating ETS because of the deficiencies in the exposure data.4 Enstrom and Kabat lament the exclusion of the earlier CPS-I report from meta-analyses of ETS exposure and CHD, but they do not discuss the methodologic limitations that led to its exclusion. Nor do the authors cite the reanalysis of the CPS-II data by Steenland et al,5 the conclusions of which do not support their views or the position of the tobacco industry.

The reviewers at the BMJ may have been persuaded that the resurvey of 681 subjects in 1999 ensured the validity of the exposure data, or that the size of the CPS-I cohort provided adequate statistical power to evaluate the relationship between ETS and any disease end point. However, respondents to the 1999 resurvey comprised only 2% of the original 35 561 married lifelong nonsmokers who originally enrolled and 5% of those who were followed after 1972. A close examination of the seemingly extensive data on the 1999 respondents provided in Tables 2 through 6 (available at http://bmj.com/cgi/content/full/326/7398/1057) reveals that the data are actually sparse; these tables include many empty cells or percentages based on fewer than five subjects.

The number of deaths from lung cancer in CPS-I is considerably smaller than in numerous other ETS studies. Enstrom and Kabat based their analysis on married, lifelong nonsmokers drawn from the 10% of subjects who live in California. Because lung cancer is rare in lifelong nonsmokers, the relatively small number of observed deaths in this subgroup gives rise to wide 95% confidence intervals that in fact overlap with relative risk estimates cited in meta-analyses by the International Agency for Research on Cancer (IARC),6 the Environmental Protection Agency (EPA),7 and others.8-9

The article selectively omits mention of studies and reviews of ETS published after 1999, as well as reports that addressed the tobacco industry's standard criticisms of the scientific literature on ETS, such as the California EPA report.10 No mention is made of the 2002 report by IARC that concluded that involuntary exposure to tobacco smoke is carcinogenic.6 Enstrom and Kabat minimize the extent of the published literature linking ETS exposure to lung cancer. Recent reviews8-9 list 51 relevant studies, many of which collected information on ETS exposure from other sources, as well as from smoking by the spouse. These studies had been conducted during time periods and in countries where the potential for exposure misclassification was substantially less than in CPS-I. Enstrom and Kabat incorrectly claim that ETS exposure data in CPS-I are comparable in quality to those of most other studies.

ACS does not endorse or agree with the methods and conclusions of the study by Enstrom and Kabat. ACS once collaborated with Enstrom, beginning in 1989, to enable him to extend follow-up of the California subgroup of CPS-I from 1972 forward. The acknowledgments at the end of the article thank two former ACS vice presidents for this assistance but fail to mention that ACS terminated its collaboration with Enstrom several years ago because of his unwillingness to address fundamental methodologic problems with this and other analyses. At no point did Enstrom inform ACS that he had communicated with Philip Morris about the potential value of the CPS-I follow-up in 199011 or that he had applied for and received funding from Philip Morris in 1997.12

Sadly, the forum in which the study by Enstrom and Kabat will be most influential is not the scientific world—most scientists will recognize the study for what it is—but in the battle for public support in communities that are considering more stringent regulations on smoking in public spaces. Misleading publicity appears repeatedly in newspapers and other community publications wherever clean air laws are being debated.13 For example, the methodologically flawed study by LeVois and Layard was recently cited in an op-ed piece in a Seattle newspaper in March 2003,14 eight years after it had been published in an obscure journal.3 The Enstrom and Kabat paper represents an even more valuable public relations resource for tobacco companies. They can refer not only to the ACS as the data source for the study but also to the prestigious BMJ as the journal in which it was published.

Michael J Thun, vice president, epidemiology and surveillance research

American Cancer Society, Atlanta, GA. mthun{at}cancer.org)


Papers p 369

Competing interests: None declared.

References

  1. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA 1998; 279:1566-1570.[Abstract/Free Full Text]
  2. US Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1989.
  3. LeVois ME, Layard MW. Publication bias in the environmental tobacco smoke/coronary heart disease epidemiologic literature. Regul Toxicol Pharmacol 1995;21:184-191.[CrossRef][ISI][Medline]
  4. Thun MJ, Henley J, Apicella L. Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. Environ Health Perspect 1999;107 suppl 6:841-846.
  5. Steenland K, Thun MJ, Lally C, Heath C Jr. Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation 1996;94:622-628.[Abstract/Free Full Text]
  6. International Agency for Research on Cancer. Involuntary smoking. Lyon, France: International Agency for Research on Cancer, 2002. http://193.51.164.11/htdocs/monographs/vol83/02-involuntary.html (accessed June 18, 2003).
  7. US Environmental Protection Agency. Respiratory health effects of passive smoking: lung cancer and other disorders. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, NIH Pub. No. 93-3605, 1993.
  8. Boffetta P. Involuntary smoking and lung cancer. Scand J Work Environ Health 2002;28 suppl 2:30-40.
  9. Zhong L, Goldberg MS, Parent ME, Hanley JA. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer 2000;27:3-18.[CrossRef][ISI][Medline]
  10. California Environmental Protection Agency. Health effects of exposure to environmental tobacco smoke: final report. Sacramento, CA: California Environmental Protection Agency, Office of Environmental Health Hazard Assessment, 1997.
  11. Letter from James Enstrom to Thomas J Borelli, Manager, Scientific Issues, Philip Morris, USA, October 22, 1990. http://legacy.library.ucsf.edu/tid/tqe58e00 (accessed June 18, 2003).
  12. Philip Morris tobacco documents. Relationship of low levels of active smoking to mortality. April 25, 1997. http://tobaccodocuments.org/pm/2063654069.html (accessed June 18, 2003).
  13. Kennedy GE, Bero LA. Print media coverage of research on passive smoking. Tob Control 1999;8:254-260.[Abstract/Free Full Text]
  14. Hellthaler G, St. John J. Secondhand alarmists blowing smoke. Seattle Post-Intelligencer March 26, 2003.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Rapid Responses:

Read all Rapid Responses

Disinformation on Medical Issues in Russia
Sergei V. Jargin, et al.
bmj.com, 5 Apr 2008 [Full text]



Student BMJ

Intimate examinations

Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.

www.student.bmj.com

Listen to the latest BMJ Interview